tradingkey.logo
tradingkey.logo
Suchen

Hims & Hers Health Inc

HIMS
Zur Watchlist hinzufügen
25.325USD
-3.815-13.09%
Trading geöffnet ETKurse um 15 Minuten verzögert
5.75BMarktkapitalisierung
44.38KGV TTM

Hims & Hers Health Inc

25.325
-3.815-13.09%

mehr Informationen über Hims & Hers Health Inc Unternehmen

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.

Hims & Hers Health Inc Informationen

BörsenkürzelHIMS
Name des UnternehmensHims & Hers Health Inc
IPO-datumSep 09, 2019
CEODudum (Andrew)
Anzahl der mitarbeiter1637
WertpapierartOrdinary Share
GeschäftsjahresendeSep 09
Addresse2269 Chestnut St
StadtSAN FRANCISCO
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl94123
Telefon14158510195
Websitehttps://www.forhims.com/
BörsenkürzelHIMS
IPO-datumSep 09, 2019
CEODudum (Andrew)

Führungskräfte von Hims & Hers Health Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.53M
-4.23%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
299.37K
-3.16%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
270.81K
-20.09%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
51.77K
--
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
--
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Dr. Delos Cosgrove, M.D.
Dr. Delos Cosgrove, M.D.
Independent Director
Independent Director
--
--
Ms. Andrea Perez
Ms. Andrea Perez
Independent Director
Independent Director
--
--
Mr. David Wells
Mr. David Wells
Lead Independent Director
Lead Independent Director
--
--
Mr. Mike Chi
Mr. Mike Chi
Chief Operating Officer
Chief Operating Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.53M
-4.23%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
299.37K
-3.16%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
270.81K
-20.09%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
51.77K
--
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
--
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Online
2.31B
98.46%
Wholesale
36.19M
1.54%
Nach RegionUSD
Name
Umsatz
Anteil
United States Revenue
2.21B
94.29%
Rest of the World Revenue
133.99M
5.71%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Online
2.31B
98.46%
Wholesale
36.19M
1.54%

Aktionärsstatistik

Aktualisiert: Sun, May 10
Aktualisiert: Sun, May 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
10.40%
JP Morgan Asset Management
6.74%
Capital World Investors
6.43%
Vanguard Portfolio Management, LLC
4.57%
Goldman Sachs & Company, Inc.
4.38%
Andere
67.48%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
10.40%
JP Morgan Asset Management
6.74%
Capital World Investors
6.43%
Vanguard Portfolio Management, LLC
4.57%
Goldman Sachs & Company, Inc.
4.38%
Andere
67.48%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
49.41%
Investment Advisor/Hedge Fund
12.84%
Research Firm
10.91%
Hedge Fund
6.28%
Individual Investor
5.42%
Bank and Trust
1.84%
Pension Fund
1.83%
Sovereign Wealth Fund
0.86%
Private Equity
0.14%
Andere
10.46%

Institutionelle Beteiligung

Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
1130
208.41M
93.60%
-37.99M
2025Q4
1061
210.10M
95.82%
-8.20M
2025Q3
970
195.39M
89.11%
-889.66K
2025Q2
893
201.00M
92.37%
-34.62M
2025Q1
847
185.19M
85.97%
-48.88M
2024Q4
739
195.19M
91.41%
-9.62M
2024Q3
627
167.49M
80.36%
-35.34M
2024Q2
588
165.89M
79.48%
-12.74M
2024Q1
503
156.70M
75.98%
-10.05M
2023Q4
463
153.90M
75.37%
-26.71M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
23.16M
10.55%
+1.08M
+4.88%
Dec 31, 2025
JP Morgan Asset Management
15.00M
6.83%
+2.13M
+16.55%
Dec 31, 2025
Capital World Investors
14.32M
6.52%
-4.46M
-23.75%
Dec 31, 2025
Goldman Sachs & Company, Inc.
9.76M
4.44%
+1.22M
+14.23%
Dec 31, 2025
Dudum (Andrew)
9.93M
4.52%
-362.12K
-3.52%
Mar 13, 2026
State Street Investment Management (US)
7.31M
3.33%
+132.31K
+1.84%
Dec 31, 2025
Geode Capital Management, L.L.C.
5.51M
2.51%
+608.95K
+12.43%
Dec 31, 2025
Renaissance Technologies LLC
4.82M
2.19%
-4.28M
-47.04%
Dec 31, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
First Trust Nasdaq Lux Digi Health Solutions ETF
3.83%
Global X HealthTech ETF
3.75%
Amplify Weight Loss Drug & Treatment ETF
3.67%
Invesco Dorsey Wright Healthcare Momentum ETF
3.66%
YieldMax Ultra Option Income Strategy ETF
2.96%
Invesco S&P MidCap 400 Pure Growth ETF
2.4%
State Street SPDR S&P Health Care Services ETF
1.94%
Amplify Online Retail ETF
1.85%
Invesco S&P MidCap 400 GARP ETF
1.65%
VanEck Social Sentiment ETF
1.53%
Mehr Anzeigen
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil3.83%
Global X HealthTech ETF
Anteil3.75%
Amplify Weight Loss Drug & Treatment ETF
Anteil3.67%
Invesco Dorsey Wright Healthcare Momentum ETF
Anteil3.66%
YieldMax Ultra Option Income Strategy ETF
Anteil2.96%
Invesco S&P MidCap 400 Pure Growth ETF
Anteil2.4%
State Street SPDR S&P Health Care Services ETF
Anteil1.94%
Amplify Online Retail ETF
Anteil1.85%
Invesco S&P MidCap 400 GARP ETF
Anteil1.65%
VanEck Social Sentiment ETF
Anteil1.53%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI